Eye health and ophthalmology companies develop diagnostics, treatments and research technologies for conditions affecting vision and the structures of the eye. Their work supports earlier disease detection, improved patient monitoring and the development of new ocular therapies.
This category includes companies working on:
Browse 26 UK eye health and ophthalmology companies below.
Non-invasive small molecule eye drops for retinal vascular disease
Foventa is a biopharmaceutical company developing non-invasive, small molecule therapeutics for retinal vascular diseases that can cause vision loss. Its lead candidate targets VEGF splicing, a mechanism underlying abnormal blood vessel growth in conditions including diabetic retinopathy and diabetic macular oedema.…
AI-powered cell simulation platform targeting ageing and age-driven diseases
Shift Bioscience is a biotechnology company developing an AI-powered virtual cell platform to identify novel therapeutic targets for cellular rejuvenation. Its proprietary single-cell ageing clock measures epigenetic age at high throughput, feeding machine learning models that predict gene combinations and small…
AI-driven natural product discovery for neurological therapeutics
Pangea Bio is a clinical-stage biotechnology company developing small molecule therapeutics for neurological and neuropsychiatric disorders. Its proprietary AI platform screens natural and plant-derived chemical space, integrating ethnobotanical data with machine learning to identify novel CNS drug candidates with…
Sustained-release ocular drug delivery for retinal disease
Re-Vana Therapeutics is a biotechnology company developing sustained-release drug delivery technologies for the treatment of serious retinal diseases. Its biodegradable hydrogel platform uses photo-crosslinking to form in-situ implants administered via intravitreal injection, enabling controlled release of biologics,…
Polymer-based rapid diagnostic technology for bacterial and fungal infections
Molecular Titans is a University of Bradford spin-out developing a patented polymer nanotechnology platform for rapid infection diagnosis. Its thermoresponsive polymers bind selectively to bacterial and fungal pathogens, producing a measurable signal within minutes rather than days. Initial applications include…
AI platform combining retinal imaging and genomics for inherited eye disease diagnosis
Eye2Gene is an AI-powered precision ophthalmology platform combining retinal imaging with genomic analysis to accelerate diagnosis of inherited retinal diseases. Using a neural network ensemble trained on tens of thousands of multimodal retinal scans, the platform predicts the likely causative gene behind a patient's…